WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies

Detalles Bibliográficos
Autores principales: Suzuki, Mikito, Hishida, Tomoyuki, Asakura, Keisuke, Asamura, Hisao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2019
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794358/
https://www.ncbi.nlm.nih.gov/pubmed/35118240
http://dx.doi.org/10.21037/med.2019.04.01
_version_ 1784640808112095232
author Suzuki, Mikito
Hishida, Tomoyuki
Asakura, Keisuke
Asamura, Hisao
author_facet Suzuki, Mikito
Hishida, Tomoyuki
Asakura, Keisuke
Asamura, Hisao
author_sort Suzuki, Mikito
collection PubMed
description
format Online
Article
Text
id pubmed-8794358
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87943582022-02-02 WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies Suzuki, Mikito Hishida, Tomoyuki Asakura, Keisuke Asamura, Hisao Mediastinum Editorial Commentary AME Publishing Company 2019-04-15 /pmc/articles/PMC8794358/ /pubmed/35118240 http://dx.doi.org/10.21037/med.2019.04.01 Text en 2019 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Editorial Commentary
Suzuki, Mikito
Hishida, Tomoyuki
Asakura, Keisuke
Asamura, Hisao
WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title_full WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title_fullStr WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title_full_unstemmed WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title_short WT1 peptide-based immunotherapy for refractory thymic epithelial malignancies
title_sort wt1 peptide-based immunotherapy for refractory thymic epithelial malignancies
topic Editorial Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794358/
https://www.ncbi.nlm.nih.gov/pubmed/35118240
http://dx.doi.org/10.21037/med.2019.04.01
work_keys_str_mv AT suzukimikito wt1peptidebasedimmunotherapyforrefractorythymicepithelialmalignancies
AT hishidatomoyuki wt1peptidebasedimmunotherapyforrefractorythymicepithelialmalignancies
AT asakurakeisuke wt1peptidebasedimmunotherapyforrefractorythymicepithelialmalignancies
AT asamurahisao wt1peptidebasedimmunotherapyforrefractorythymicepithelialmalignancies

Ejemplares similares